Pamela Van Schaack - Costa Mesa CA, US Kenneth Tong - Carlsbad CA, US
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
A61K 39/08
US Classification:
424239100
Abstract:
Methods of treating one or more autoimmune disorders include a step of administering a Clostridial neurotoxin, such as a botulinum toxin, to a patient that has an autoimmune disorder. In one aspect, a method includes a step of administering the neurotoxin to the thymus gland or near the thymus gland of the patient. In another aspect, a method includes a step of administering the neurotoxin in combination with administering a cytokine inhibitor to the patient. Compositions are also described.
Treatment Of Autoimmune Disorders With A Neurotoxin
Pamela D. Van Schaack - Costa Mesa CA, US Kenneth L. Tong - Carlsbad CA, US
Assignee:
ALLERGAN, INC. - Irvine CA
International Classification:
A61K 39/08 A61P 37/00 A61K 39/395
US Classification:
4241451, 4242391
Abstract:
Methods of treating one or more autoimmune disorders include a step of administering a Clostridial neurotoxin, such as a toxin, to a patient that has an autoimmune disorder. In one aspect, a method includes a step of administering the neurotoxin to the thymus gland or near the thymus gland of the patient. In another aspect, a method includes a step of administering the neurotoxin in combination with administering a cytokine inhibitor to the patient. Compositions are also described.
Uc Irvine
University of California, San Francisco
Doctorates, Doctor of Pharmacy
Skills:
Biotechnology Medical Affairs Clinical Trials Managed Care Strategy Pharmaceutical Industry Clinical Development Medicine Pharmaceutics Oncology Medical Writing Gastroenterology Medical Devices Dermatology Drug Development Neurology Infectious Diseases Biopharmaceuticals Cardiology Commercialization